ferrous gluconate 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definition	Drug id	CAS RN
	4491	299-29-6

Description:

Molecule	Description
Synonyms: sodium ferric gluconate complex ferrous gluconate iron gluconate ferroglyconicum glucoferron	iron important in this cpd; RN given refers to ferrous cpd Molecular weight: 446.14 Formula: C12H22FeO14 CLOGP: LIPINSKI: None HAC: None HDO: None TPSA: 265.04 ALOGS: ROTB: None

Molecule

Description

Synonyms:

sodium ferric gluconate complex
ferrous gluconate
iron gluconate
ferroglyconicum
glucoferron

iron important in this cpd; RN given refers to ferrous cpd

Molecular weight: 446.14
Formula: C12H22FeO14
CLOGP:
LIPINSKI: None
HAC: None
HDO: None
TPSA: 265.04
ALOGS:
ROTB: None

Drug dosage:

Dose	Unit	Route
0.20	g	O

ADMET properties:

None

Approvals:

Date	Agency	Company	Orphan
Feb. 18, 1999	FDA	SANOFI AVENTIS US

FDA Adverse Event Reporting System (Female)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Reversible airways obstruction	216.94	16.33	58	17589	1784	63469591
Vital capacity decreased	211.05	16.33	56	17591	1672	63469703
Sputum culture positive	198.50	16.33	56	17591	2111	63469264
Bronchial secretion retention	184.86	16.33	56	17591	2717	63468658
Presbyacusis	153.72	16.33	49	17598	2816	63468559
Pleural fibrosis	144.47	16.33	49	17598	3423	63467952
Pleural thickening	129.11	16.33	43	17604	2840	63468535
Deafness neurosensory	128.43	16.33	49	17598	4806	63466569
Eosinophil count increased	125.12	16.33	61	17586	10867	63460508
Blood magnesium increased	119.08	16.33	41	17606	2997	63468378
Oesophageal spasm	114.13	16.33	40	17607	3083	63468292
Upper-airway cough syndrome	113.78	16.33	58	17589	11360	63460015
Multiple allergies	106.17	16.33	59	17588	13743	63457632
Epigastric discomfort	106.12	16.33	47	17600	6733	63464642
Oesophageal pain	103.85	16.33	39	17608	3662	63467713
Smear cervix abnormal	101.06	16.33	36	17611	2910	63468465
Bone cyst	98.47	16.33	33	17614	2221	63469154
Obstructive airways disorder	86.51	16.33	60	17587	20639	63450736
Cyst	83.85	16.33	51	17596	14048	63457327
Osteosclerosis	80.93	16.33	33	17614	3855	63467520
Pulmonary mass	77.29	16.33	58	17589	22538	63448837
Urticaria	73.41	16.33	150	17497	165652	63305723
Osteopenia	70.39	16.33	52	17595	19733	63451642
Lymphoedema	68.77	16.33	42	17605	11650	63459725
Hyperhidrosis	68.47	16.33	114	17533	107722	63363653
Full blood count abnormal	62.05	16.33	59	17588	31658	63439717
Blood pressure decreased	60.20	16.33	82	17565	64940	63406435
Respiratory tract infection	59.02	16.33	65	17582	41418	63429957
Skin fissures	57.17	16.33	37	17610	11351	63460024
Skin lesion	56.05	16.33	55	17592	30666	63440709
Abdominal pain	55.15	16.33	193	17454	293263	63178112
Blood potassium increased	53.90	16.33	43	17604	18266	63453109
Deformity	53.88	16.33	36	17611	11648	63459727
Flushing	49.82	16.33	81	17566	75006	63396369
Hypotension	47.54	16.33	175	17472	272429	63198946
Allergic sinusitis	47.32	16.33	16	17631	1106	63470269
CFTR gene mutation	46.58	16.33	10	17637	116	63471259
Alopecia	44.64	16.33	19	17628	337517	63133858
Osteoarthritis	44.22	16.33	88	17559	95255	63376120
Dyspnoea	44.03	16.33	324	17323	660989	62810386
Sputum culture	43.78	16.33	11	17636	263	63471112
Endodontic procedure	43.12	16.33	20	17627	3187	63468188
Heart rate decreased	42.98	16.33	58	17589	45502	63425873
Discoloured vomit	42.69	16.33	14	17633	880	63470495
Myocardial infarction	42.54	16.33	89	17558	99804	63371571
Toothache	41.96	16.33	38	17609	19161	63452214
Dry eye	41.71	16.33	54	17593	40707	63430668
Occult blood	41.25	16.33	15	17632	1286	63470089
Localised infection	35.66	16.33	43	17604	30167	63441208
Sleep apnoea syndrome	35.27	16.33	42	17605	29091	63442284
Tooth disorder	34.76	16.33	41	17606	28116	63443259
Exostosis	34.49	16.33	33	17614	17829	63453546
Wound	34.28	16.33	3	17644	163260	63308115
Blood iron decreased	33.88	16.33	30	17617	14691	63456684
Blood pressure fluctuation	33.51	16.33	52	17595	46265	63425110
Tinnitus	31.56	16.33	44	17603	35584	63435791
Fluid retention	31.23	16.33	58	17589	59628	63411747
Renal impairment	31.15	16.33	73	17574	88282	63383093
Mite allergy	30.17	16.33	10	17637	650	63470725
Completed suicide	29.72	16.33	3	17644	145670	63325705
Cystitis	29.48	16.33	54	17593	54937	63416438
Internal haemorrhage	28.96	16.33	18	17629	5147	63466228
Vomiting	27.89	16.33	257	17390	559360	62912015
Synovitis	27.23	16.33	9	17638	186909	63284466
Pancreatitis relapsing	27.03	16.33	10	17637	900	63470475
Chest discomfort	26.65	16.33	79	17568	109890	63361485
Lip pruritus	26.64	16.33	10	17637	937	63470438
Infusion related reaction	26.16	16.33	136	17511	245385	63225990
Abdominal pain upper	26.03	16.33	120	17527	206324	63265051
Medication error	25.12	16.33	49	17598	52235	63419140
Agitation	23.99	16.33	52	17595	59705	63411670
Skin discolouration	22.66	16.33	39	17608	37789	63433586
Anaphylactic reaction	22.63	16.33	54	17593	66046	63405329
Skin depigmentation	22.59	16.33	9	17638	990	63470385
Anal incontinence	22.36	16.33	23	17624	13553	63457822
Choluria	21.97	16.33	6	17641	200	63471175
Bone hypertrophy	21.71	16.33	7	17640	417	63470958
Malaise	21.68	16.33	193	17454	415761	63055614
Loss of consciousness	21.52	16.33	77	17570	118044	63353331
Burning sensation	21.45	16.33	47	17600	54360	63417015
Therapeutic reaction time decreased	20.63	16.33	11	17636	2359	63469016
Toxicity to various agents	20.61	16.33	23	17624	247227	63224148
Blood creatinine increased	20.23	16.33	62	17585	87782	63383593
Product use in unapproved indication	19.36	16.33	13	17634	179067	63292308
Syncope	19.28	16.33	74	17573	117311	63354064
Depression	18.98	16.33	106	17541	196386	63274989
Pallor	18.95	16.33	32	17615	30536	63440839
Therapeutic response decreased	18.67	16.33	48	17599	61477	63409898
Sleep disorder	18.26	16.33	57	17590	81509	63389866
Therapeutic product effect incomplete	18.24	16.33	6	17641	125050	63346325
Sinusitis	17.90	16.33	22	17625	226631	63244744
Anxiety	17.58	16.33	112	17535	217429	63253946
Contusion	17.45	16.33	10	17637	150034	63321341
Cough	17.44	16.33	140	17507	292603	63178772
Cushingoid	17.00	16.33	16	17631	8469	63462906
Febrile neutropenia	16.73	16.33	6	17641	118443	63352932
Respiratory alkalosis	16.65	16.33	10	17637	2691	63468684
Headache	16.40	16.33	106	17541	633135	62838240

FDA Adverse Event Reporting System (Male)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Appendicolith	453.82	21.46	141	8491	8460	34939839
Appendicitis	378.73	21.46	141	8491	14666	34933633
Cardiogenic shock	305.08	21.46	143	8489	26475	34921824
Stress	302.15	21.46	148	8484	30199	34918100
Ascites	245.28	21.46	149	8483	46422	34901877
Abdominal distension	223.67	21.46	153	8479	58339	34889960
Ventricular fibrillation	207.75	21.46	105	8527	22849	34925450
Blood phosphorus increased	188.02	21.46	71	8561	7650	34940649
Multiple organ dysfunction syndrome	182.67	21.46	151	8481	76415	34871884
Hyponatraemia	174.56	21.46	152	8480	82539	34865760
General physical health deterioration	148.45	21.46	170	8462	128099	34820200
Abdominal pain	124.48	21.46	176	8456	163442	34784857
Constipation	123.39	21.46	160	8472	136822	34811477
Sepsis	114.78	21.46	171	8461	166390	34781909
Vitamin D deficiency	96.14	21.46	42	8590	6566	34941733
Dry mouth	94.51	21.46	70	8562	30095	34918204
Myasthenia gravis	84.67	21.46	39	8593	6901	34941398
Vomiting	78.52	21.46	182	8450	247439	34700860
Blood uric acid increased	78.23	21.46	41	8591	9583	34938716
C-reactive protein decreased	73.61	21.46	25	8607	1977	34946322
Drug intolerance	58.85	21.46	73	8559	59497	34888802
Nausea	58.38	21.46	200	8432	339708	34608591
Blood cholesterol increased	49.83	21.46	41	8591	20502	34927797
Drug therapy	48.93	21.46	16	8616	1125	34947174
Analgesic therapy	46.89	21.46	15	8617	983	34947316
Dental caries	44.64	21.46	22	8610	4517	34943782
Haematochezia	44.30	21.46	56	8576	46478	34901821
Gastrointestinal disorder	42.50	21.46	47	8585	33901	34914398
Sleep disorder therapy	42.47	21.46	14	8618	1009	34947290
Hyperphosphataemia	42.14	21.46	21	8611	4416	34943883
Incorrect route of product administration	38.89	21.46	31	8601	14814	34933485
Colitis	38.44	21.46	47	8585	37703	34910596
Condition aggravated	37.23	21.46	118	8514	192078	34756221
Blood pressure fluctuation	35.18	21.46	37	8595	25212	34923087
Drug hypersensitivity	34.40	21.46	67	8565	80462	34867837
Peripheral swelling	30.66	21.46	62	8570	76479	34871820
Somnolence	30.04	21.46	77	8555	111039	34837260
Hypophosphataemia	28.83	21.46	23	8609	11003	34937296
Diabetes mellitus inadequate control	26.79	21.46	24	8608	13440	34934859
Bacterial infection	25.56	21.46	26	8606	17037	34931262
Neuralgia	24.42	21.46	24	8608	15089	34933210
Toxicity to various agents	23.58	21.46	10	8622	200352	34747947
Withdrawal hypertension	22.82	21.46	6	8626	195	34948104
Drug interaction	22.54	21.46	14	8618	225932	34722367
Off label use	21.72	21.46	177	8455	419347	34528952

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event term	Likelihood ratio	Likelihood ratio threshold	Patients taking drug having adverse event	Patients taking drug not having adverse event	Patients not taking drug having adverse event	Patients not taking drug not having adverse event
Appendicolith	421.83	15.24	140	23970	8411	79711867
Appendicitis	301.10	15.24	140	23970	20654	79699624
Cardiogenic shock	216.58	15.24	143	23967	41771	79678507
Vital capacity decreased	189.81	15.24	53	24057	1763	79718515
Reversible airways obstruction	189.15	15.24	55	24055	2121	79718157
Stress	169.43	15.24	161	23949	79451	79640827
Ascites	168.84	15.24	157	23953	75405	79644873
Blood phosphorus increased	157.03	15.24	72	24038	10275	79710003
Ventricular fibrillation	153.06	15.24	104	24006	31822	79688456
Sputum culture positive	151.53	15.24	53	24057	3728	79716550
Abdominal pain	150.09	15.24	350	23760	389219	79331059
Bronchial secretion retention	147.29	15.24	53	24057	4051	79716227
Presbyacusis	136.95	15.24	45	24065	2615	79717663
Abdominal distension	132.73	15.24	172	23938	119478	79600800
Oesophageal spasm	117.93	15.24	43	24067	3413	79716865
Pleural fibrosis	117.21	15.24	45	24065	4122	79716156
Multiple organ dysfunction syndrome	112.28	15.24	159	23951	120087	79600191
Pleural thickening	108.85	15.24	39	24071	2943	79717335
Oesophageal pain	105.49	15.24	42	24068	4237	79716041
Smear cervix abnormal	103.36	15.24	36	24074	2500	79717778
Multiple allergies	102.45	15.24	54	24056	10406	79709872
Upper-airway cough syndrome	102.30	15.24	56	24054	11637	79708641
Blood magnesium increased	95.54	15.24	37	24073	3469	79716809
Deafness neurosensory	95.35	15.24	45	24065	6853	79713425
Vomiting	87.50	15.24	415	23695	665413	79054865
Eosinophil count increased	87.43	15.24	58	24052	17047	79703231
Epigastric discomfort	83.74	15.24	43	24067	7853	79712425
Bone cyst	82.22	15.24	33	24077	3400	79716878
Osteosclerosis	80.90	15.24	34	24076	3937	79716341
Obstructive airways disorder	77.32	15.24	69	24041	31390	79688888
Hyponatraemia	71.79	15.24	163	23947	177685	79542593
Lymphoedema	70.57	15.24	45	24065	12368	79707910
Blood uric acid increased	69.97	15.24	46	24064	13314	79706964
Cyst	68.50	15.24	46	24064	13794	79706484
Sepsis	64.13	15.24	203	23907	269225	79451053
Myasthenia gravis	62.38	15.24	39	24071	10360	79709918
Osteopenia	61.13	15.24	48	24062	18316	79701962
Full blood count abnormal	60.93	15.24	68	24042	40406	79679872
Pulmonary mass	60.34	15.24	58	24052	28976	79691302
Blood pressure fluctuation	60	15.24	87	24023	67058	79653220
Completed suicide	55.91	15.24	5	24105	245762	79474516
Deformity	55.05	15.24	35	24075	9570	79710708
Nausea	54.07	15.24	482	23628	956714	78763564
Urticaria	53.99	15.24	150	23960	185051	79535227
Toxicity to various agents	52.82	15.24	31	24079	421509	79298769
Dry eye	52.11	15.24	60	24050	36871	79683407
C-reactive protein decreased	51.55	15.24	22	24088	2646	79717632
Vitamin D deficiency	51.18	15.24	39	24071	14240	79706038
Skin fissures	49.73	15.24	37	24073	13036	79707242
Drug therapy	44.94	15.24	16	24094	1185	79719093
Respiratory tract infection	44.83	15.24	64	24046	48625	79671653
Endodontic procedure	44.50	15.24	20	24090	2723	79717555
Analgesic therapy	43.74	15.24	15	24095	994	79719284
Hyperhidrosis	43.45	15.24	122	23988	151370	79568908
Allergic sinusitis	41.96	15.24	14	24096	853	79719425
General physical health deterioration	41.51	15.24	179	23931	275059	79445219
CFTR gene mutation	41.12	15.24	9	24101	105	79720173
Constipation	41.11	15.24	182	23928	282868	79437410
Toothache	39.82	15.24	39	24071	19931	79700347
Sleep disorder therapy	39.68	15.24	14	24096	1010	79719268
Dry mouth	36.96	15.24	82	24028	87937	79632341
Flushing	36.80	15.24	82	24028	88186	79632092
Tooth disorder	35.96	15.24	42	24068	26191	79694087
Hyperphosphataemia	35.96	15.24	23	24087	6353	79713925
Exostosis	35.64	15.24	34	24076	16824	79703454
Sputum culture	35.00	15.24	9	24101	217	79720061
Discoloured vomit	34.68	15.24	14	24096	1464	79718814
Gastrointestinal disorder	34.62	15.24	98	24012	122107	79598171
Cystitis	34.18	15.24	59	24051	52673	79667605
Osteoarthritis	34.05	15.24	79	24031	87230	79633048
Sleep apnoea syndrome	33.65	15.24	48	24062	36430	79683848
Pyrexia	32.83	15.24	101	24009	678608	79041670
Localised infection	32.56	15.24	48	24062	37527	79682751
Skin lesion	31.39	15.24	50	24060	41794	79678484
Infusion related reaction	31.13	15.24	145	23965	230092	79490186
Sleep disorder	30.69	15.24	75	24035	85602	79634676
Fluid retention	30.39	15.24	66	24044	69743	79650535
Heart rate decreased	30.07	15.24	66	24044	70250	79650028
Dyspnoea	29.77	15.24	392	23718	856633	78863645
Blood potassium increased	29.21	15.24	40	24070	29235	79691043
Alopecia	28.96	15.24	17	24093	231338	79488940
Febrile neutropenia	27.49	15.24	18	24092	230981	79489297
Peripheral swelling	26.88	15.24	156	23954	269461	79450817
Drug abuse	26.69	15.24	8	24102	162683	79557595
Blood pressure decreased	26.46	15.24	78	24032	99388	79620890
Neutropenia	26.20	15.24	29	24081	287681	79432597
Rheumatoid arthritis	25.80	15.24	128	23982	208342	79511936
Tinnitus	25.39	15.24	47	24063	44286	79675992
Drug intolerance	25.16	15.24	151	23959	263968	79456310
Blood iron decreased	25.07	15.24	27	24083	15407	79704871
Wound	24.77	15.24	3	24107	116176	79604102
Hypophosphataemia	24.21	15.24	30	24080	19883	79700395
Skin discolouration	24.13	15.24	44	24066	40990	79679288
Synovitis	23.68	15.24	8	24102	150726	79569552
Dental caries	23.41	15.24	23	24087	11797	79708481
Lip pruritus	22.65	15.24	9	24101	903	79719375
Abdominal pain upper	22.63	15.24	130	23980	223689	79496589
Intentional overdose	21.95	15.24	3	24107	105957	79614321
Pancreatitis relapsing	21.88	15.24	9	24101	987	79719291
Thrombocytopenia	21.75	15.24	29	24081	265230	79455048
Interstitial lung disease	21.50	15.24	4	24106	112596	79607682
Hand deformity	21.39	15.24	3	24107	103916	79616362
Internal haemorrhage	20.96	15.24	19	24091	8814	79711464
Product use in unapproved indication	20.91	15.24	27	24083	250332	79469946
Therapeutic reaction time decreased	20.67	15.24	13	24097	3488	79716790
Mite allergy	20.05	15.24	9	24101	1221	79719057
Bone hypertrophy	19.02	15.24	7	24103	570	79719708
Myocardial infarction	18.64	15.24	107	24003	184022	79536256
Neuralgia	18.63	15.24	35	24075	33349	79686929
Fibromyalgia	18.60	15.24	52	24058	64288	79655990
Drug interaction	18.49	15.24	64	24046	415119	79305159
Blood pressure increased	18.34	15.24	118	23992	211242	79509036
White blood cell count decreased	18.23	15.24	18	24092	188270	79532008
Nephrogenic systemic fibrosis	18.16	15.24	15	24095	6145	79714133
Joint swelling	18.06	15.24	149	23961	288497	79431781
Anaphylactic reaction	17.98	15.24	61	24049	83682	79636596
Withdrawal hypertension	17.79	15.24	6	24104	378	79719900
Malaise	17.74	15.24	226	23884	489643	79230635
Medication error	17.47	15.24	53	24057	68589	79651689
Platelet count decreased	17.30	15.24	20	24090	194644	79525634
Migraine	16.44	15.24	61	24049	87432	79632846
Coma	16.41	15.24	5	24105	100644	79619634
Pulmonary function test abnormal	16.37	15.24	12	24098	4132	79716146
Haematochezia	15.56	15.24	60	24050	87585	79632693
Sinusitis	15.39	15.24	22	24088	195479	79524799
Cough	15.36	15.24	174	23936	366615	79353663

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Source	Code	Description
ATC	B03AA03	BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS IRON PREPARATIONS Iron bivalent, oral preparations
ATC	B03AD05	BLOOD AND BLOOD FORMING ORGANS ANTIANEMIC PREPARATIONS IRON PREPARATIONS Iron in combination with folic acid
FDA CS	M0011718	Iron
MeSH PA	D006397	Hematinics
MeSH PA	D006401	Hematologic Agents
FDA EPC	N0000177913	Parenteral Iron Replacement

Drug Use | Suggest Off label Use Form| |View source of the data|

Disease	Relation	SNOMED_ID	DOID
Anemia of prematurity	indication	47100003	DOID:11243
Iron deficiency anemia	indication	87522002
Peptic ulcer	contraindication	13200003	DOID:750
Gastroenteritis	contraindication	25374005	DOID:2326
Hemosiderosis	contraindication	39011001	DOID:12119
Hemolytic anemia	contraindication	61261009	DOID:583
Ulcerative colitis	contraindication	64766004	DOID:8577
Diverticular disease	contraindication	397881000
Hemochromatosis	contraindication	399187006	DOID:2352
Repeated Blood Transfusions	contraindication

🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

None

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

ID	Source
D02394	KEGG_DRUG
4024159	VUID
N0000148626	NUI
34089-81-1	SECONDARY_CAS_RN
4017678	VANDF
4019180	VANDF
4021178	VANDF
4024159	VANDF
CHEBI:31608	CHEBI
CHEMBL3833303	ChEMBL_ID
CHEMBL3991443	ChEMBL_ID
CHEMBL1201494	ChEMBL_ID
C011819	MESH_SUPPLEMENTAL_RECORD_UI
DB14488	DRUGBANK_ID
U1B11I423Z	UNII
DB09517	DRUGBANK_ID
24942	RXNORM
189358	MMSL
4724	MMSL
5409	MMSL
7975	MMSL
d03822	MMSL
d04387	MMSL
000834	NDDF
007777	NDDF
116130008	SNOMEDCT_US
26736008	SNOMEDCT_US
387147005	SNOMEDCT_US
786421005	SNOMEDCT_US
C0060277	UMLSCUI
23616740	PUBCHEM_CID
6047-12-7	SECONDARY_CAS_RN

Pharmaceutical products:

Product	Category	Ingredients	NDC	Form	Quantity	Route	Marketing	Label
Ferrlecit	HUMAN PRESCRIPTION DRUG LABEL	1	0024-2792	INJECTION	12.50 mg	INTRAVENOUS	NDA	25 sections
Ferrlecit	HUMAN PRESCRIPTION DRUG LABEL	1	0024-2792	INJECTION	12.50 mg	INTRAVENOUS	NDA	25 sections
Ferrlecit	HUMAN PRESCRIPTION DRUG LABEL	1	0024-2794	INJECTION	12.50 mg	INTRAVENOUS	NDA	26 sections
Ferrlecit	HUMAN PRESCRIPTION DRUG LABEL	1	0024-2794	INJECTION	12.50 mg	INTRAVENOUS	NDA	26 sections
Sodium Ferric Gluconate Complex in Sucrose	HUMAN PRESCRIPTION DRUG LABEL	1	0143-9298	INJECTION	12.50 mg	INTRAVENOUS	ANDA	24 sections
Sodium Ferric Gluconate Complex in Sucrose	HUMAN PRESCRIPTION DRUG LABEL	1	0143-9298	INJECTION	12.50 mg	INTRAVENOUS	ANDA	24 sections
Sodium Ferric Gluconate Complex in Sucrose	HUMAN PRESCRIPTION DRUG LABEL	1	0143-9570	INJECTION	12.50 mg	INTRAVENOUS	ANDA	24 sections
Sodium Ferric Gluconate Complex in Sucrose	HUMAN PRESCRIPTION DRUG LABEL	1	0143-9570	INJECTION	12.50 mg	INTRAVENOUS	ANDA	24 sections
CitraNatal Bloom	HUMAN PRESCRIPTION DRUG LABEL	6	0178-0813	TABLET, FILM COATED	13.20 mg	ORAL	unapproved drug other	15 sections
CitraNatal Bloom	HUMAN PRESCRIPTION DRUG LABEL	6	0178-0813	TABLET, FILM COATED	13.20 mg	ORAL	unapproved drug other	15 sections
CitraNatal Bloom	HUMAN PRESCRIPTION DRUG LABEL	6	0178-0813	TABLET, FILM COATED	13.20 mg	ORAL	unapproved drug other	15 sections
CitraNatal 90 DHA	HUMAN PRESCRIPTION DRUG LABEL	16	0178-0821	TABLET	5 mg	ORAL	unapproved drug other	11 sections
CitraNatal 90 DHA	HUMAN PRESCRIPTION DRUG LABEL	16	0178-0821	TABLET	5 mg	ORAL	unapproved drug other	11 sections
BioFerr 90	HUMAN PRESCRIPTION DRUG LABEL	6	44523-732	TABLET, FILM COATED	13.20 mg	ORAL	Unapproved drug other	20 sections